| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2025 | Sep 4, 2025 | OCULAR THERAPEUTIX, INC | Officer | Sell | 51.3 | -1,066 | -0.34% | ✗ | $13.3K |
| Jan 31, 2025 | Feb 4, 2025 | OCULAR THERAPEUTIX, INC | Officer | Sell | 42.5 | -17,420 | -8.26% | ✗ | $136.2K |
| Feb 3, 2024 | Feb 6, 2024 | OCULAR THERAPEUTIX, INC | CFO | Buy | 91.3 | +67,848 | 20.62% | ✗ | $30.2K |
| Jan 31, 2024 | Feb 2, 2024 | OCULAR THERAPEUTIX, INC | CFO | Sell | 46.3 | -6,433 | -4.40% | ✗ | $31.8K |
| Feb 6, 2023 | Feb 8, 2023 | OCULAR THERAPEUTIX, INC | CFO | Sell | 41.3 | -6,476 | -4.44% | ✓ | $27.5K |
| Jun 14, 2019 | Jun 17, 2019 | OCULAR THERAPEUTIX, INC | CFO | Buy | 91.3 | +2,500 | 11.60% | ✗ | $10.8K |
| Aug 14, 2018 | Aug 15, 2018 | OCULAR THERAPEUTIX, INC | CFO | Buy | 95.0 | +12,500 | 260.42% | ✗ | $78.6K |
| Dec 7, 2017 | Dec 8, 2017 | OCULAR THERAPEUTIX, INC | CFO | Buy | 91.3 | +4,800 | 100.00% | ✗ | $19.2K |